Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
A4346 AminophyllineTarget: Phosphodiesterases (PDEs)Summary: Pan-PDE inhibitor
-
A4347 Methotrexate2 CitationTarget: Folate AnalogueSummary: Folate antagonist,inhibits DFHR
-
A4349 S- (+)-RolipramSummary: CAMP-specific PDE4 inhibitor
-
A4351 PluriSIn #1 (NSC 14613)Target: Stearoyl-CoA 9-desaturase (SCD-1)Summary: SCD1 inhibitor
-
A4355 Tosedostat (CHR2797)1 CitationTarget: AminopeptidasesSummary: Aminopeptidase inhibitor
-
A4356 Varespladib (LY315920)Target: PhospholipasesSummary: HnsPLA inhibitor,potent and selective
-
A4358 U-104Target: Carbonic AnhydrasesSummary: CAIX inhibitor
-
A4362 TioxoloneTarget: Carbonic AnhydrasesSummary: CAI inhibitor
-
A4364 MethazolamideTarget: Carbonic AnhydrasesSummary: Carbonic anhydrase inhibitor
-
A4365 LovastatinTarget: HMG-CoA ReductasesSummary: HMG-CoA reductase inhibitor